Ria Health Appoints Martin Rosenzweig, MD, to Advisory Role

Ria Health Strengthens Leadership with New Appointment

Ria Health, a key player in the telehealth treatment industry for Alcohol Use Disorder (AUD), proudly announces the appointment of Dr. Martin Rosenzweig, a recognized leader in the behavioral health sector, to its Board of Directors. Dr. Rosenzweig brings an extensive background of over 25 years in managed care, psychiatric disorders, and substance abuse treatment, aligning perfectly with Ria Health's mission to enhance access to effective, evidence-based alcohol treatment.

Experience and Impact in Behavioral Health

Prior to his role at Ria Health, Dr. Rosenzweig served as the Chief Medical Officer at Optum Behavioral Health, where he spearheaded initiatives that significantly improved access to quality care for individuals facing psychiatric challenges. His work has been particularly impactful in addressing the opioid crisis, establishing him as a leading figure in the realm of behavioral healthcare.

Dr. Rosenzweig's contributions to national programs focused on medication-assisted treatment (MAT) and the advancement of psychiatric disability management have left a lasting mark on the industry. His expertise and commitment will undoubtedly bolster Ria Health's initiatives.

A Vision for Effective Alcohol Treatment

Upon joining the board, Dr. Rosenzweig expressed his enthusiasm for Ria Health's innovative approach to alcohol treatment. He stated, "I am excited to join Ria Health’s board and support an organization that is making tremendous advancements in the treatment of alcohol use disorder. Ria Health is uniquely positioned to provide scalable, effective care through its innovative telehealth model and research partnerships. I look forward to contributing to their continued growth and helping more people access life-changing treatment."

Carol Vallone, Chair of the Board at Ria Health, praised the addition of Dr. Rosenzweig to the board. She mentioned, "We are thrilled to have Martin join us on the board. His wealth of knowledge and experience in behavioral health, paired with his commitment to improving patient care, align perfectly with Ria Health’s mission. I value the perspective Martin will bring to our work in making effective, compassionate alcohol treatment widely accessible."

Ria Health’s Innovative Approach

Ria Health has developed a comprehensive, tech-driven platform centered around supporting individuals combating alcohol misuse. The organization’s model integrates personalized physician and coaching support, clinically approved medications, and innovative tools such as Bluetooth-enabled breathalyzers that empower patients to monitor their progress. Recent studies have highlighted the effectiveness of Ria Health’s approach, showing a remarkable 50 percent reduction in alcohol consumption among participants within just 90 days.

Dr. John Mendelson, Co-founder and Chief Medical Officer at Ria Health, commented on the significance of Dr. Rosenzweig joining the team: "Martin’s deep expertise in behavioral health and managed care is invaluable as we continue to expand our services nationwide. His strategic insight and experience will help guide us as we work to meet the growing demand for accessible, evidence-based AUD treatment."

With rising alcohol misuse rates observed in the aftermath of the pandemic and nearly 29.5 million individuals across the U.S. affected by AUD, Ria Health is unwavering in its dedication to providing uplifting and effective care. Dr. Rosenzweig’s appointment further emphasizes the company’s commitment to delivering high-quality treatment solutions at scale.

About Ria Health

Founded in 2016, Ria Health is at the forefront of transforming the treatment landscape for alcohol use disorder. Led by a diverse team of healthcare professionals, technology specialists, and entrepreneurial veterans, Ria Health's multidisciplinary approach includes doctors, nurse practitioners, addiction counselors, and seasoned nonprofit workers, all dedicated to providing compassionate and effective care to those in need.

Frequently Asked Questions

1. Who is Martin Rosenzweig, MD?

Martin Rosenzweig, MD, is a prominent leader in behavioral health with over 25 years of experience in managed care and substance use treatment.

2. What role will he play at Ria Health?

Dr. Rosenzweig will serve on the Board of Directors, contributing his expertise to enhance Ria Health’s initiatives in treating alcohol use disorder.

3. What is Ria Health known for?

Ria Health is recognized for its telehealth treatment programs aimed at helping individuals struggling with alcohol misuse through comprehensive and personalized care.

4. How has Ria Health been effective?

Research indicates that patients using Ria Health's services have reduced their alcohol consumption by 50 percent within 90 days.

5. What commitment does Ria Health have?

Ria Health is committed to providing compassionate and effective treatment for alcohol use disorder, especially in the context of rising misuse rates.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.